Gaylord v. Presence Pain Care

2023 IL App (3d) 210572-U
CourtAppellate Court of Illinois
DecidedAugust 15, 2023
Docket3-21-0572
StatusUnpublished
Cited by1 cases

This text of 2023 IL App (3d) 210572-U (Gaylord v. Presence Pain Care) is published on Counsel Stack Legal Research, covering Appellate Court of Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Gaylord v. Presence Pain Care, 2023 IL App (3d) 210572-U (Ill. Ct. App. 2023).

Opinion

NOTICE: This order was filed under Supreme Court Rule 23 and is not precedent except in the limited circumstances allowed under Rule 23(e)(1).

2023 IL App (3d) 210572-U

Order filed August 15, 2023 ____________________________________________________________________________

IN THE

APPELLATE COURT OF ILLINOIS

THIRD DISTRICT

CURTIS GAYLORD, ) Appeal from the Circuit Court ) of the 12th Judicial Circuit, Plaintiff-Appellant, ) Will County, Illinois. ) v. ) Appeal No. 3-21-0572 ) Circuit No. 20-L-17 PRESENCE PAIN CARE and AEGIS ) SCIENCES CORPORATION, ) Honorable ) John C. Anderson, Defendants-Appellees. ) Judge, Presiding. ____________________________________________________________________________

JUSTICE HETTEL delivered the judgment of the court. Justices McDade and Peterson concurred in the judgment. ____________________________________________________________________________

ORDER

¶1 Held: The trial court did not err in dismissing plaintiff’s three-count amended complaint pursuant to sections 2-615 and 2-619(a)(9) of the Code of Civil Procedure, and the court’s dismissal with prejudice was not an abuse of discretion.

¶2 Plaintiff, Curtis Gaylord, appeals from the Will County circuit court’s order dismissing

his complaint against Presence Pain Care (Presence) and Aegis Sciences Corporation (Aegis),

alleging that defendants violated his constitutional rights by excluding him from a controlled

substance medication program after testing positive for cocaine. Plaintiff argues, inter alia, that the trial court erred in dismissing his three-count amended complaint with prejudice under

sections 2-615 and 2-619 of the Code of Civil Procedure (Code) (735 ILCS 5/2-615, 2-619 (West

2020)) because he sufficiently alleged claims of negligence, breach of contract, and

constitutional violations. We affirm.

¶3 I. BACKGROUND

¶4 On September 22, 2016, Gaylord entered a contract for controlled substance prescriptions

with Presence, a clinic responsible for administering a pain medication program in affiliation

with Saint Joseph Medical Center. According to the terms of the contract, Gaylord agreed to

comply with random drug testing to document the proper use of the medication, as well as

confirm compliance with the program. Paragraph 6 of the contract specifically stated that if

Gaylord violated any of conditions of the agreement, including the use of illegal drugs, his

treatment at Presence “may be ended immediately.” (Emphasis in original.).

¶5 On January 5, 2018, Gaylord completed an oral drug test administered and collected at

Presence. The sample was tested by Aegis, a laboratory contracted by Presence to analyze the

specimen samples and report the results. The Aegis lab report indicated that Gaylord’s sample

tested positive for cocaine. On March 29, 2018, Gaylord attended a scheduled appointment at the

clinic and was informed by a nurse practitioner that he had been dismissed from the controlled

substance prescription program because he tested positive for an illegal drug.

¶6 On January 7, 2020, Gaylord filed a one-count complaint against Presence and Aegis as a

self-represented litigant, claiming that defendants violated his constitutional rights by excluding

him from the program without affording him the right to contest or appeal the “false-positive”

finding of cocaine in the drug test. Both defendants filed motions to dismiss for failure to state a

2 cause of action pursuant to section 2-615 of the Code. After the parties briefed their motions,

Gaylord orally requested leave to file an amended complaint, which the trial court granted.

¶7 On November 17, 2020, Gaylord filed a three-count amended complaint, asserting

negligence and breach of contract in addition to his constitutional claim. Count I of the complaint

claimed the lab results were inaccurate and defendants were negligent in failing to retest the

sample at Gaylord’s request. Gaylord alleged that Aegis reported the positive test result to

Presence on January 9, 2018, and that between January 9 and March 28, 2018, he received no

notice from Presence or Aegis that he tested positive and was given no opportunity “to prove a

false-positive.” Gaylord alleged that on March 29, 2018, he informed the nurse practitioner that

the result “had to be a false[-]positive,” but she refused to consider his explanation. He then

contacted Aegis and informed an employee that he had a false-positive result. Aegis retested the

specimen and again reported that the sample tested positive for cocaine. Gaylord asserted that

defendants had a close relationship with him and owed him a duty under Stinson v. Physicians

Immediate Care, Ltd., 269 Ill. App. 3d 659 (1995), that neither defendant “afforded [him] a

chance to prove a false[-]positive,” and that, as a result of their negligence, he suffered emotional

and physical harm.

¶8 Counts II and III contained two narrative paragraphs without supporting argument. Count

II asserted a breach of contract claim against Presence. Gaylord alleged, in a single paragraph,

that “[Presence’s] acts and/or omissions was [sic] a “ ‘Breach of Contract’ being

‘unconscionable’ that plaintiff would agree to signing away any ‘due process’ or ‘fairness’ as

stated by defendant, nurse practitioner.” Count III summarily claimed that defendants violated

Gaylord’s fourth, fifth, and fourteenth amendment rights (U.S. Const., amend. IV, V, XIV) by

excluding him from the program without allowing him the opportunity to contest the lab results.

3 In a single paragraph, Gaylord alleged that “his oral fluids (salvia) is [sic] deemed a ‘property

right’ and fairness is mandatory and not discretional.”

¶9 Both defendants filed motions to dismiss. Presence claimed that Gaylord’s complaint

should be dismissed pursuant to sections 2-615 and 2-619 of the Code. It argued that the

amended complaint should be dismissed under section 2-615 for failure to plead a cause of

action and that count II should be dismissed under section 2-619(a)(9) based on the terms of the

controlled substance prescription contract. Aegis argued that Gaylord failed to state a viable

cause of action against it and sought dismissal solely under section 2-615. In a written response,

Gaylord again cited Stinson and maintained that his complaint was sufficient to state a cause of

action. He also requested leave to file a second amended complaint.

¶ 10 On October 22, 2021, the trial court conducted a hearing on the motions via Zoom.

Gaylord did not attend. At the conclusion of the hearing, the court granted defendants’ motions

and dismissed Gaylord’s amended complaint with prejudice. The written court order granting the

dismissal stated “Motions to Dismiss are granted with prejudice” and noted that Gaylord failed to

appear for the hearing.

¶ 11 Gaylord filed a motion to vacate, which was denied. He then filed a motion to reconsider,

claiming that he did not attend the October 22 hearing because he had difficulty accessing the

proceedings electronically. A hearing was held during which the court assured Gaylord that the

order dismissing his complaint was based on the merits rather than his failure to appear. The

court issued a written order denying Gaylord’s motion to reconsider, which stated that the

complaint was “[d]ismissed with prejudice on 2-615 and 2-619 grounds,” and further clarified

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Huggins v. Board of Education of the City of Chicago
2024 IL App (1st) 230615-U (Appellate Court of Illinois, 2024)

Cite This Page — Counsel Stack

Bluebook (online)
2023 IL App (3d) 210572-U, Counsel Stack Legal Research, https://law.counselstack.com/opinion/gaylord-v-presence-pain-care-illappct-2023.